FinVector
Kuopio
About FinVector
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. They are authorised under EMA for the production of gene therapy products for clinical and commercial supply.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $48.2M
- Last round: Debt Financing (Jun 2023)
- Website: finvector.com
- Phone: +4407795065336
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/finvector-32714 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.